Princeton Alpha Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-17,216
Closed -$2.14M 512
2017
Q1
$2.14M Sell
17,216
-6,827
-28% -$817K 0.72% 8
2016
Q4
$2.78M Buy
24,043
+8,839
+58% +$984K 0.57% 22
2016
Q3
$1.59M Buy
+15,204
New +$1.65M 0.3% 73
2016
Q2
Sell
-10,195
Closed -$1.02M 1098
2016
Q1
$1.02M Buy
+10,195
New +$1.05M 0.17% 202
2015
Q2
Sell
-21,676
Closed -$2.5M 1033
2015
Q1
$2.5M Buy
+21,676
New +$2.59M 0.54% 32
2014
Q1
Sell
-3,064
Closed -$259K 809
2013
Q4
$259K Buy
+3,064
New +$242K 0.19% 235

Other funds holding CELG

Princeton Alpha Management's CELG Position: Q2 2017 in Review

Princeton Alpha Management sold out of Celgene Corp (CELG) in Q2 2017, closing a stake of 17,216 shares — an estimated $2.14M sold.

Princeton Alpha Management first reported a position in CELG in Q4 2013 and held it in 6 quarters. The position peaked at $2.78M in Q4 2016. 1,428 funds tracked by Wall St. Rank hold CELG as of Q2 2017.

  • Princeton Alpha Management reported no remaining Celgene Corp position as of Q2 2017 after selling out during the quarter.
  • Princeton Alpha Management sold 17,216 Celgene Corp shares in Q2 2017, an estimated $2.14M.
  • Princeton Alpha Management first reported a position in Celgene Corp in Q4 2013 and held it in 6 quarters.
  • Princeton Alpha Management's Celgene Corp position peaked at $2.78M in Q4 2016.
  • 1,428 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2017.

Based on Princeton Alpha Management's 13F filing for Q2 2017.